|
[1]YAN LB, RAO HY, MA YJ, et al.Hepatitis B virus infection in Chinese patients HCV infection:prevalence, clinical characteristics, viral interactions and host genotypes:a nationwide cross-sectional study[J].BMJ Open, 2016, 6 (10) :e012016.
|
|
[2]YU G, CHI X, WU R, et al.Replication inhibition of hepatitis B virus and hepatitis C virus in coinfected patients in Chinese population[J].PLo S One, 2015, 10 (9) :e0139015.
|
|
[3]STANAWAY JD, FLAXMAN AD, NAGHAVI M, et al.The global burden of viral hepatitis from 1990 to 2013:findings from the Global Burden of Disease Study 2013[J].Lancet, 2016, 388 (10049) :1081-1088.
|
|
[4]AASLD/IDSA HCV Guidance Panel.Hepatitis C guidance:recommendations for testing, managing, and treating adults infected with hepatitis C virus[J].Hepatology, 2015, 62 (3) :932-954.
|
|
[5]ZHANG N, XU CJ, YU WY, et al.Current status and research progress in HBV/HCV co-infection[J].Int J Dig Dis, 2015, 35 (3) :190-193. (in Chinese) 张宁, 徐成军, 于伟燕, 等.HBV/HCV重叠感染的现状与研究进展[J].国际消化病杂志, 2015, 35 (3) :190-193.
|
|
[6]JAMMA S, HUSSAIN G, LAU DT.Current concepts of HBV/HCV coinfection:coexistence, but not necessarily in harmony[J].Curr Hepat Rep, 2010, 9 (4) :260-269.
|
|
[7]CHEN YS, LI L, CUI FQ, et al.A sero-epidemiological study on hepatitis C in China[J].Chin J Epidemiol, 2011, 32 (9) :888-891.
|
|
[8]LOK AS, Mc MAHON BJ.Chronic hepatitis B[J].Hepatology, 2007, 45 (2) :507-539.
|
|
[9]FUKUDA R, ISHIMURA N, NIIGAKI M, et al.Serologically silent hepatitis B virus coinfection in patients with hepatitis C virusassociated chronic liver disease:clinical and virological significance[J].J Med Virol, 1999, 58 (3) :201-207.
|
|
[10]WANG C, JI D, CHEN J, et al.Hepatitis due to reactivation of hepatitis B virus in endemic areas among patients with hepatitis C treated with direct-acting antiviral agents[J].Clin Gastroenterol Hepatol, 2017, 15 (1) :132-136.
|
|
[11]LIU CJ, CHEN PJ, CHEN DS.Dual chronic hepatitis B virus and hepatitis C virus infection[J].Hepatol Int, 2009, 3 (4) :517-525.
|
|
[12]KONDO Y, UENO Y, NINOMIYA M, et al.Sequential immunological analysis of HBV/HCV co-infected patients during PegIFN/RBV therapy[J].J Gastroenterol, 2012, 47 (12) :1323-1335.
|
|
[13]WIEGAND SB, JAROSZEWICZ J, POTTHOFF A, et al.Dominance of HCV is associated with lower quantitative HBs Ag and higher serum interferon-gamma-induced protein 10 levels in HBV/HCV-coinfected patients[J].Clin Microbiol Infect, 2015, 21 (7) :710.e1-e9.
|
|
[14]MEISSNER EG, WU D, OSINUSI A, et al.Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome[J].J Clin Invest, 2014, 124 (8) :3352-3363.
|
|
[15]CHEN G, WANG C, CHEN J, et al.Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents:a systematic review and meta-analysis[J].Hepatology, 2017, 66 (1) :13-26.
|
|
[16]SAGNELLI E, COPPOLA N, MESSINA V, et al.HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course[J].Hepatology, 2002, 36 (5) :1285-1291.
|
|
[17]POLLICINO T, SQUADRITO G, CERENZIA G, et al.Hepatitis B virus maintains its pro-ncogenic properties in the case of occult HBV infection[J].Gastroenterology, 2004, 126:102-110.
|
|
[18]LIU CJ, CHU YT, SHAU WY, et al.Treatment of patients with dual hepatitis C and B by peginterferonαand ribavirin reduced risk of hepatocellular carcinoma and mortality[J].Gut, 2014, 63 (3) :506-514.
|
|
[19]UYANIKOGLU A, AKYUZ F, BARAN B, et al.Co-infection with hepatitis B does not alter treatment response in chronic hepatitis C[J].Clin Res Hepatol Gastroenterol, 2013, 37 (5) :485-490.
|
|
[20]HORNER SM, GALE M Jr.Regulation of hepatic innate immunity by hepatitis C virus[J].Nat Med, 2013, 19 (7) :879-888.
|
|
[21]European Association for the Study of the Liver.EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection[J].J Hepatol, 2017, 67 (2) :370-398.
|
|
[22]European Association for the Study of the Liver.EASL recommendations on treatment of hepatitis C 2016[J].J Hepatology, 2017, 66 (1) :153-194.
|
DownLoad: